Synapse - Center for Hematologic Malignancies

Search Within

Center for Hematologic Malignancies

Results (13553)

Excellent outcomes for limited-stage diffuse large B-cell lymphoma in the rituximab era: A retrospective analysis from Memorial Sloan-Kettering Cancer Center

Meeting Abstract

Kumar, A.; Maragulia, J. C.; Lunning, M. A.; Moskowitz, C. H.; Zelenetz, A. D.
Blood (2013)

Fulltext@MSK | Save

JAK2 dependent GM-CSF signaling triggers SRSF2 phosphorylation: A potential cause of mutation-independent RNA splicing aberrancy in CMML

Meeting Abstract

Kunigal, S.; Teer, J.; Painter, J.; Yoder, S. J.; Kim, E.; Zhang, L.; Lancet, J. E.; Komrokji, R. S.; Abdel-Wahab, O.; List, A.; more...
Blood (2013)

Fulltext@MSK | Save

In vitro growth inhibition, target modulation and drug synergy in pediatric leukemia by the novel proteasome inhibitor carfilzomib

Meeting Abstract

Jayanthan, A.; Ruan, Y.; Hagerty, M.; Shah, R.; Truong, T.; Lewis, V. A.; Boklan, J.; Trippett, T.; Gore, L.; Narendran, A.
Blood (2013)

Fulltext@MSK | Save

Phase I trial of the targeted alpha-particle nano-generator actinium-225 ((225)Ac)-lintuzumab (anti-CD33) in combination with low-dose cytarabine (LDAC) for older patients with untreated acute myeloid leukemia (AML)

Meeting Abstract

Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Douer, D.; Estey, E. H.; Kantarjian, H. M.; Cicic, D.; Scheinberg, D. A.
Blood (2013)

Fulltext@MSK | Save

Chronic myeloid leukemia after adjuvant treatment for breast cancer: Is it therapy related?

Meeting Abstract

Kishtagari, A.; Bowman, I. A.; Tallman, M. S.; Douer, D.; Berman, E.; Maslak, P. G.; Brentjens, R. J.; Stein, E. M.
Blood (2013)

Fulltext@MSK | Save

T-cell depleted allogeneic hematopoietic stem cell transplantation for patients with relapsed multiple myeloma and high-risk cytogenetics permits long-lasting remissions in the absence of graft-versus-host disease

Meeting Abstract

Koehne, G.; Devlin, S. M.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S.
Blood (2013)

Fulltext@MSK | Save

Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)

Meeting Abstract

Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
Blood (2013)

Fulltext@MSK | Save

Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform

Meeting Abstract

Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
Blood (2013)

Fulltext@MSK | Save

Outcomes in patients with acute lymphoblastic leukemia in first or second complete remission receiving ex-vivo T-cell depleted or unmodified allografts: Comparison of results at two institutions

Meeting Abstract

Hobbs, G. S.; Hilden, P.; Hamdi, A.; Goldberg, J. D.; Poon, M.; Ledesma, C.; Devlin, S.; Rondon, G.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
Blood (2013)

Fulltext@MSK | Save

Autologous hematopoietic cell transplantation (HCT) is superior to allogeneic transplantation for acute promyelocytic leukemia in second complete remission (CR2)

Meeting Abstract

Holter-Chakrabarty, J. L.; Rubinger, M.; Grigg, A.; Szer, J.; Selby, G.; Rowe, J. M.; Le Rademacher, J.; Wang, H. L.; Weisdorf, D. J.; Tallman, M. S.
Blood (2013)

Fulltext@MSK | Save